Related Experiment Videos

"Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally

Isabel García-Cao1, Marta García-Cao, Juan Martín-Caballero

  • 1Spanish National Center of Biotechnology, Department of Immunology and Oncology, Campus de Cantoblanco, Madrid E-28049, Spain.

The EMBO Journal
|November 12, 2002
PubMed

Insights

Increasing tumor suppressor p53 gene copies in mice enhances cancer resistance. These "super p53" mice show improved DNA damage response and protection from cancer without premature aging.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The tumor suppressor p53 is crucial for preventing cancer by inducing cell cycle arrest and apoptosis in response to cellular stress.
  • Understanding p53's role is vital for developing novel cancer therapies.

Purpose of the Study:

  • To generate and characterize mice with extra copies of the p53 gene to investigate its impact on cancer resistance.
  • To assess the functional activity and potential side effects of increased p53 levels.

Main Methods:

  • Generation of transgenic mice carrying supernumerary copies of the p53 gene (p53-tg).
  • Validation of the p53-tg allele's functionality in a p53-null background.
  • Characterization of "super p53" mice (possessing both endogenous and transgenic p53 alleles) for DNA damage response, cancer susceptibility, and aging phenotypes.

Main Results:

  • The p53-tg allele functionally replicates the endogenous p53 gene.
  • "Super p53" mice exhibit an enhanced response to DNA damage.
  • These mice demonstrate significant protection against cancer compared to normal mice without signs of premature aging.

Conclusions:

  • Enhancing p53 gene dosage is a viable strategy to increase cancer resistance.
  • This genetic modification confers cancer protection without detrimental effects like premature aging.
  • The findings support the potential of modulating p53 levels for cancer prevention.

Related Concept Videos